Navigation Links
To Patent or Not-A Question of Life

Giant drug makers Novartis, is filing a petition against a court ruling that seeks to stop the patenting of one of its anti-cancer drugs. //

What makes this news significant is that its outcome will determine the quality of life for an AIDS patient; a nightmare or a manageable crisis.

Novartis is backing its right to patent a modified version of its drug Glivec produced in India, used to treat leukemia. If it wins its case this will mean the cost of the drug shooting to almost ten times its present value and a move towards more stringent rules on drug patenting.

This in turn will lead to drugs used for treating cancers and AIDS, as like ARV or anti retroviral drugs, being patented too, making it much more costlier and hence out of reach for millions of poor AIDS sufferers in developing countries.

At present people across developing countries are protesting this move.

India has been an important source of affordable generic medicines for quite a while. This being because it did not grant pharmaceutical patents until 2005, when it was forced to comply with World Trade Organization rules on intellectual property.

A lot of generic drugs used for treating AIDS are produced in India. The same holds for Brazil and Thailand.

This makes such drugs affordable and able to be used in international programs for the treatment of AIDS.

Says Dr. Unni Karunakara a director with Doctors Without Borders, a humanitarian agency, ”Novartis is trying to shut down the pharmacy of the developing world”.

This he says will prevent the supply of affordable AIDS drugs to developing countries resulting in millions of people stranded without life saving drugs.

In defense Novartis says that patents enable income needed for drug research and production. The company says that AIDS affected persons soon grow resistant to antiretroviral drugs and newer ones need to be developed. This needs money and that ca n be derived through patenting of drugs.

Yet for many people across developing countries the ruling expected from the Chennai High Court of India will be waited for, with crossed fingers.
AN
'"/>




Related medicine news :

1. Indian Government Keen On JE Vaccine Supply And Patenting Of Indian Medicine Formulations
2. HIV Patients Opposes Patenting Of AIDS Drug
3. Provigil Patent Extension Accorded To Cephalon
4. AIDS Sufferers Protest against Proposed Patent for Tenofovir
5. POLY Medicure Ltd Applies for 8 Patents, 2 FDA Approvals
6. Venus Remedies Files 5th International Patent Application
7. US Court Rules Against Lupin in Ramipril Patent Case
8. Patent for Seminal RNAi innovation Cleared in Australia
9. Canada: On Popular Demand, Tamiflu finds a Berth in the Directory of Patent Drugs
10. Compellis Pharmaceuticals Gets Patent for Obesity-Fighting Nasal Spray CP404
11. A Patented Device for Rapid Diagnosis of Diseases
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/2/2016)... ... ... Rijuven Corp launches rejiva ( http://www.rejiva.com ), a unique wearable technology that measures ... on the market can deliver all that rejiva can. , “Rejiva promotes relaxation and ... than the usual heart rate and steps taken”, adds Evens Augustin, CEO of Rijuven. ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... to needy individuals and families from eight different sites throughout Miami-Dade and Broward ... Over 1,000 volunteers worked very hard on Thanksgiving morning by putting together individual ...
(Date:11/30/2016)... Boston, Massachusetts (PRWEB) , ... November 30, 2016 ... ... is proud to announce that we have been designated as a Cigna Infertility ... meet or exceed rigorous performance standards. , “It’s an honor to be ...
(Date:11/30/2016)... ... November 30, 2016 , ... ... treatment has announced the opening of a new eating disorder treatment center location ... outpatient treatment for adults and adolescents, both males and females ages 10 and ...
(Date:11/30/2016)... ... 2016 , ... The Clinical Data Interchange Standards Consortium (CDISC) ... goes into effect next month. Sponsors whose studies start after December 17, 2016 ... The current FDA Data Standards Catalog specifies the use of CDISC standards: ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... YORK , December 2, 2016 ... the trading session in red, while the Dow Jones Industrial ... at the close of US markets, which prompted Stock-callers this ... stocks: NuVasive Inc. (NASDAQ: NUVA ), Smith & ... (NASDAQ: NXTM ), and Cesca Therapeutics Inc. (NASDAQ: ...
(Date:12/2/2016)... -- Research and Markets has announced the addition ... Technologies, Markets and Companies" to their offering. ... , , ... The market value of drug delivery technologies and the anticancer ... given according to organs involved and the types of cancer as ...
(Date:12/2/2016)... , Dec. 1, 2016  Today, Simpson Healthcare Executives, ... honor of being selected as winners of multiple awards ... Executives Website at the PLATINUM level, Blue Zones Menu ... at the GOLD Level, and our proprietary 3ConneX Platform ... Simpson Healthcare Executives, we are excited to showcase our ...
Breaking Medicine Technology: